First ever recorded study for CAP on Pediatric Cannula infections

September 24, 2024
|In Research
|By Adtec Healthcare

🚨 Exciting News! 🚨

We are thrilled to share a groundbreaking study by Dr. Schlöglhofer, recently published in the Artificial Organs journal from Wiley. This study highlights the remarkable safety and efficacy of using SteriPlas Premium Cold Plasma for managing infections on Berlin Heart EXCOR cannulas.

 

🌟 This is the first publication to demonstrate the potential of CAP therapy for treating infections and inflammation in pediatric patients with paracorporeal pulsatile VADs.

 

Key findings show that SteriPlas treatments:

  • Do not alter the surface structure of cannulas, as confirmed by SEM micrographs.
  • Lead to significant improvements in DESTINE wound staging.
  • Drastically reduce bacterial load and inflammatory markers.
  • Achieve these results with no observed side effects.

 

This study marks an exciting step forward in infection management for pediatric VAD patients. To read the full publication, visit: Wiley Library.